The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts by Skaar, Eric P.
Pearls
The Battle for Iron between Bacterial Pathogens and
Their Vertebrate Hosts
Eric P. Skaar*
Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
Iron is a vital nutrient for virtually all forms of life. The
requirement for iron is based on its role in cellular processes
ranging from energy generation and DNA replication to oxygen
transport and protection against oxidative stress. Bacterial
pathogens are not exempt from this iron requirement, as these
organisms must acquire iron within their vertebrate hosts in order
to replicate and cause disease.
Vertebrates Sequester Iron from Invading
Pathogens
One of the first lines of defense against bacterial infection is the
withholding of nutrients to prevent bacterial outgrowth in a process
termed nutritional immunity. The most significant form of
nutritional immunity is the sequestration of nutrient iron [1]. The
vast majority of vertebrate iron is intracellular, sequestered within
the iron storage protein ferritin or complexed within the porphyrin
ring of heme as a cofactor of hemoglobin or myoglobin. Further,
the aerobic environment and neutral pH of serum ensures that
extracellular iron is insoluble and hence difficult to access by
invading pathogens. This difficulty is enhanced by the serum
protein transferrin, which binds iron with an association constant of
approximately 10
36 [2]. Taken together, these factors ensure that
the amount of free iron available to invading bacteria is vastly less
than what is required to replicate and cause disease (Figure 1A).
The importance of nutritional immunity as it pertains to iron is
exemplified by the increased susceptibility to infection of
individuals with iron overload due to thalassemia and primary
hemochromatosis, two of the most common genetic diseases of
humans [3]. The degree to which transferrin is iron saturated can
vary from 25% to 30% in a healthy individual to 100% in patients
with hemochromatosis, negating the antimicrobial properties of
transferrin-mediated iron sequestration [2]. The impact of this
iron overload is perhaps best demonstrated by the enhanced
susceptibility of hemochromatosis patients to Vibrio vulnificus
infections [4]. Whereas V. vulnificus is killed by normal blood and
rarely causes infection in healthy individuals, it grows rapidly in
blood from patients with hemochromatosis, leading to a high risk
of fatal infections in this cohort [4]. Moreover, the administration
of excess iron increases the virulence of numerous pathogens in
animal models, further highlighting the protection provided by
nutritional immunity [2,5].
Many Bacterial Pathogens Sense Iron Depletion as
a Signal That They Are within a Vertebrate Host
Vertebrates are devoid of free iron, ensuring that all bacterial
pathogens encounter a period of iron starvation upon entering their
hosts. In keeping with this, bacterial pathogens have evolved to
sense iron depletion as a marker of vertebrate tissue. This sensing
typically involves transcriptional control mediated by the iron-
dependent repressor known as Fur (ferric uptake regulator) [6]. Fur
binds to target sequences in the promoters of iron-regulated genes
and repressestheir expression inthe presenceofiron. Inthe absence
of iron, Fur-mediated repression is lifted and the genes are
transcribed. Fur orthologs have been identified in numerous genera
from both Gram-negative and Gram-positive bacteria and con-
tribute to the virulence of both animal and plant pathogens [7].
A number of genes encoding for proteins involved in iron
utilization have been reported to be positively regulated by Fur
during iron-replete conditions [8]. This positive regulation occurs
through Fur-mediated repression of a small RNA that represses
genes encoding iron utilization proteins. This second level of
regulation prevents the use of iron by non-essential enzymes
during times of iron starvation. RNA-dependent regulation of iron
utilization is a conserved process that has been identified in
multiple bacterial pathogens, including Vibrio sp., Pseudomonas
aeruginosa, Escherichia coli, Shigella flexneri, and Bacillus subtilis [8].
Many high G+C content Gram-positive bacteria express an
additional iron-dependent repressor belonging to the DtxR family.
The DtxR family was named for its founding member, the
diphtheria toxin repressor. In fact, one of the first iron-dependent
virulence factors described was diphtheria toxin produced by
Corynebacterium diphtheria [2]. DtxR family members negatively
regulate genes involved in processes ranging from iron acquisition
to virulence factor expression [5].
In addition to sensing alterations in iron levels, bacterial
pathogens can also sense heme as a marker of vertebrate tissue.
Heme-responsive activators have been identified in Serratia
marcescens, the pathogenic Bordetella, C. diphtheriae, Bacillus anthracis,
and Staphylococcus aureus [5,9,10,11]. Heme-sensing systems pre-
sumably alert bacterial pathogens when they are in contact with
vertebrate tissues rich in heme, triggering the expression of systems
involved in heme-iron acquisition and metabolism.
All Bacterial Pathogens Can Circumvent Iron
Withholding
In order to thrive within vertebrates, bacteria must possess
mechanisms to evade nutritional immunity. Perhaps the most
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PLoS Pathogens | www.plospathogens.org 1 August 2010 | Volume 6 | Issue 8 | e1000949Figure 1. A representative battle during the war for iron. (A) In a healthy individual iron is largely intracellular, sequestered within ferritin or as
a cofactor of heme complexed to hemoglobin within erythrocytes. Any extracellular free iron is rapidly bound by circulating transferrin. Hemoglobin
or heme that is released as a result of natural erythrocyte lysis is captured by haptoglobin and hemopexin, respectively. Taken together, these factors
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Borrelia burgdorferi, the causative agent of Lyme disease. B. burgdorferi
has evolved to not require iron for growth by substituting man-
ganese in its metal-requiring enzymes [12]. Most pathogens have
not evolved this simple defense strategy and instead circumvent
iron withholding through high-affinity iron uptake mechanisms
that compete against host-mediated sequestration. These uptake
systems can be divided into three main categories: siderophore-
based systems, heme acquisition systems, and transferrin/lactofer-
rin receptors (Figure 1C).
Siderophores are low molecular weight iron-binding complexes
that are secreted from bacteria. Siderophores bind iron with an
association constant that can exceed 10
50, enabling bacteria to
compete with iron sequestration by transferrin and lactoferrin [2].
Upon removing iron from host proteins, iron-loaded siderophores
are bound by cognate receptors expressed at the bacterial surface.
The siderophore–iron complex is then internalized into the
bacterium and the iron is released for use as a nutrient source.
The importance of siderophores to bacterial virulence is demon-
strated by the decreased fitness of siderophore-defective strains in
animal models of infection [2,7].
Heme acquisition systems typically involve surface receptors
that recognize either heme or heme bound to hemoproteins such
as hemoglobin or hemopexin. Heme is then removed from
hemoproteins and transported through the envelope of bacteria
into the cytoplasm. Once inside the cytoplasm, the iron is released
from heme through the action of heme oxygenases or reverse
ferrochelatase activity [13–15]. Bacterial pathogens can also
elaborate secreted heme-scavenging molecules that remove heme
from host hemoproteins. These molecules, known as hemophores,
are functionally analogous to siderophores but are proteins that
target heme, whereas siderophores are small molecules that target
iron atoms [16]. As is the case with siderophore transport systems,
genetic defects in heme acquisition systems reduce bacterial fitness
in many animal models of infection [2,7].
In addition to acquiring iron from transferrin and lactoferrin
through siderophore-based mechanisms, some bacteria are
capable of direct recognition of these host proteins. The most
well-studied transferrin and lactoferrin receptors are present in
pathogenic members of the Neisseriaceae and Pasteurellaceae [7].
These proteins are modeled to recognize human transferrin or
lactoferrin, leading to iron removal and subsequent transport into
the bacterial cytoplasm. Human challenge models with Neisseria
gonorrhoeae suggest that gonococci expressing both lactoferrin and
transferrin receptors exhibit a selective advantage within the host,
underscoring the importance of this iron acquisition strategy to
these organisms [5,17].
Targeting Bacterial Iron Acquisition as a Second
Layer of Defense against Infection
A second layer of nutritional immunity employed by vertebrates
is to combat siderophore-mediated iron acquisition through the
production of siderocalin [18]. Siderocalin, also referred to as
lipocalin-2 or neutrophil gelatinase-associated lipocalin (NGAL), is
a protein that is secreted by neutrophils in response to infection.
Siderocalin binds enterobactin, the primary siderophore of many
enteric bacteria, and sequesters the siderophore–iron complex,
preventing bacterial uptake. Mice lacking siderocalin exhibit
increased sensitivity to enterobactin-expressing bacteria, demon-
strating the pathophysiological relevance of this anti-siderophore
defense system [19].
The requirement for iron by bacterial pathogens ensures that
iron acquisition systems are expressed and surface exposed during
infection. This fact has established surface-exposed iron receptors
as viable vaccine candidates for the prevention of bacterial
infection. The enterobactin receptor FetA from Neisseria meningitidis
[20], the siderophore receptor IroN from Escherichia coli [21], the
hemoglobin receptor HgbA from Haemophilus ducreyi [22], surface
proteins of the S. aureus Isd heme uptake machinery [23], and a
combination of E. coli iron acquisition proteins [24] are examples
of iron utilization systems that have been proposed as candidate
vaccines.
Bacterial Pathogens Are Leading the Arms Race
for Nutrient Iron
Resistance to siderocalin is a conserved strategy across multiple
pathogenic microbes. A primary bacterial defense against side-
rocalin involves the production of stealth siderophores. These
molecules represent structurally modified enterobactin-type side-
rophores that are resistant to siderocalin binding. The Gram-
positive pathogen B. anthracis produces the siderophore petrobac-
tin, which incorporates a 3,4-dihydroxybenzoyl chelating subunit
that prevents siderocalin binding [25]. Similarly, Salmonella
Typhimurium produces salmochelin, a glycoslyated derivative of
enterochelin that is not targeted by siderocalin [26]. The
production of stealth siderophores is the most recently uncovered
layer in the arms race for nutrient iron during host–pathogen
interactions. Undoubtedly, we have not yet discovered the
complete armamentarium in this battle that has tremendous
implications for the outcome of bacterial infections.
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